Accelerating access to and delivery of new health technologies of tubercolosis, malaria and negleted tropical diseases: supporting countries to achieve universal health coverage

Accelerating access to and delivery of new health technologies of tubercolosis, malaria and negleted tropical diseases: supporting countries to achieve universal health coverage

Completedon 31 Jan, 2023
Planned End Date
Feb 2023
Evaluation Type
Project
Management Response
Yes
Evaluation Budget
$80,000
  • Evaluation Information
Evaluation Title
Accelerating access to and delivery of new health technologies of tubercolosis, malaria and negleted tropical diseases: supporting countries to achieve universal health coverage
Quantum Project Number
00110744
Plan Period
Status
Completed
Type
Project
Management Response
Yes
Plan Date
28 Feb, 2023
Quality Assessment
Yes
Completion Date
31 Jan, 2023
Joint Programme
No
Joint Evaluation
No
Budget
$80,000
GEF Evaluation
No
Expenditure
$40,000
Stakeholders
Project implementing partners (WHO, TDR and PATH); UNDP COs, national government partners
Source of Funding
Government of Japan
Countries
Bureau for Policy and Programme Support
  • Corporate Outcome and Output

    UNDP Strategic Plan 2022-2025

Output 2.1 Open, agile, accountable and future-ready governance systems in place to co-create and deliver solutions to accelerate SDG achievement

Goal 3. Ensure healthy lives and promote well-being for all at all ages

3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

3.b Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

1: Governance